Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets

OBJECTIVE: To test the hypothesis that dimethyl fumarate (Tecfidera, BG-12) affects B-cell subsets in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: Peripheral blood B cells were compared for surface marker expression in patients with RRMS prior to initiation of treatment, aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundy, Steven K., Wu, Qi, Wang, Qin, Dowling, Catherine A., Taitano, Sophina H., Mao, Guangmei, Mao-Draayer, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784801/
https://www.ncbi.nlm.nih.gov/pubmed/27006972
http://dx.doi.org/10.1212/NXI.0000000000000211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784801/
https://www.ncbi.nlm.nih.gov/pubmed/27006972
http://dx.doi.org/10.1212/NXI.0000000000000211

Ejemplares similares